The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug ...

( NewsNation) — Novo Nordisk has ended a partnership with U.S. telehealth company Hims & Hers, citing deceptive marketing and ...

Tesla shares rise sharply after the electric-vehicle company launched its highly anticipated robo-taxi service in Austin, ...